FDA Drug recall D-0395-2021
NP Thyroid 15 Thyroid Tablets, USP 1/4 grain (15 mg), packaged in a) 100-count bottles (NDC 42192-327-01) and b) 7-count bottles (NDC 42192…
- FDA Drug
- Class I
- terminated
- Published 2021-06-02
On 2021-06-02 the FDA classified a Class I recall of NP Thyroid 15 Thyroid Tablets, USP 1/4 grain (15 mg), packaged in a) 100-count bottles (NDC 42192-327-01) and b) 7-count bottles (NDC 42192… by Acella Pharmaceuticals, citing subpotent Drug.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0395-2021 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2021-04-29 |
| Published | 2021-06-02 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Acella Pharmaceuticals |
| Distribution | US |
Product
NP Thyroid 15 Thyroid Tablets, USP 1/4 grain (15 mg), packaged in a) 100-count bottles (NDC 42192-327-01) and b) 7-count bottles (NDC 42192-327-07), Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005
Reason
Subpotent Drug
Identifiers
| ndc | 42192-327-01 |
|---|---|
| ndc | 42192-327-30 |
| ndc | 42192-327-90 |
| ndc | 42192-329-01 |
| ndc | 42192-329-30 |
| ndc | 42192-329-10 |
| ndc | 42192-329-90 |
| ndc | 42192-330-01 |
| ndc | 42192-330-30 |
| ndc | 42192-330-10 |
| ndc | 42192-330-90 |
| ndc | 42192-331-01 |
| ndc | 42192-331-30 |
| ndc | 42192-331-10 |
| ndc | 42192-331-90 |
| ndc | 42192-328-01 |
| ndc | 42192-328-30 |
| ndc | 42192-328-90 |
| ndc | 42192-327-07 |
| code_info | Lots: a) M327D20-1, M327D20-3 Exp. 03/31/2022, M327H19-3A Exp. 07/31/2021, M327L19-1 Exp. 04/30/2021; b) M327D20-1 Exp. 03/31/2022 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Other recalls by Acella Pharmaceuticals
- NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 3…
FDA Drug · Class II · 2026-05-13 · Acella Pharmaceuticals - Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC…
FDA Drug · Class II · 2025-10-15 · Acella Pharmaceuticals - Sodium Sulfacetamide 10% - Sulfur 5% Cleanser, Rx Only, 6 oz (170.3 g) Bottle, Manufactured for Acela Pharmaceuticals, LLC Alphareta, GA 30…
FDA Drug · Class III · 2024-05-15 · Acella Pharmaceuticals - Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads, Net weight 3.7g (60 cleansing pads Net weight 3.7 g each per carton,) Rx Only, Manufactu…
FDA Drug · Class III · 2022-12-07 · Acella Pharmaceuticals - Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05, packaged in 10 x 5 mL vials per carton, NDC 42192-614-30, Rx only, Manufact…
FDA Drug · Class III · 2022-11-30 · Acella Pharmaceuticals
All Acella Pharmaceuticals recalls
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0395-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.